Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enoxaparin”

239 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 239 results

Large-scale testing (Phase 3)Ended earlyNCT00206089
What this trial is testing

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events

Who this might be right for
Thromboembolism
AstraZeneca 3,300
Large-scale testing (Phase 3)Ended earlyNCT00714597
What this trial is testing

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility

Who this might be right for
Venous Thromboembolism
Sanofi 421
Large-scale testing (Phase 3)Ended earlyNCT04492254
What this trial is testing

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients

Who this might be right for
COVID-19
Thrombosis Research Institute 219
Post-approval studies (Phase 4)Study completedNCT03664180
What this trial is testing

Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI

Who this might be right for
STEMI - ST Elevation Myocardial Infarction
Beijing Anzhen Hospital 2,989
Post-approval studies (Phase 4)Study completedNCT01729559
What this trial is testing

Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Who this might be right for
Venous Thromboembolic DiseaseDeep Vein ThrombosisPulmonary Embolism
Scripps Health 495
Not applicableStudy completedNCT00456001
What this trial is testing

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Brigham and Women's Hospital 200
Not applicableNot Yet RecruitingNCT07384598
What this trial is testing

Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure Treated or Not With Continuous Veno-veinous Hemofiltration.

Who this might be right for
ThromboprophylaxisCritical IllnessIntensive Care (ICU)
Clinique Saint Pierre Ottignies 60
Post-approval studies (Phase 4)Study completedNCT03568838
What this trial is testing

Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention

Who this might be right for
Myocardial Infarction
Sheffield Teaching Hospitals NHS Foundation Trust 100
Large-scale testing (Phase 3)Looking for participantsNCT03083184
What this trial is testing

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

Who this might be right for
Tunnelled Hemodialysis Catheter Infection
University Hospital, Clermont-Ferrand 400
Testing effectiveness (Phase 2)UnknownNCT04540926
What this trial is testing

Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia

Who this might be right for
COVID 19 Pneumonia
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 200
Testing effectiveness (Phase 2)Study completedNCT00375609
What this trial is testing

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Who this might be right for
Thromboembolism
Portola Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT00077792
What this trial is testing

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)

Who this might be right for
Myocardial InfarctionAcute ST-Segment Elevation
Sanofi 20,506
Early research (Phase 1)Study completedNCT02171559
What this trial is testing

Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 29
Not applicableEnded earlyNCT05819112
What this trial is testing

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Who this might be right for
Venous Thromboembolism
Sanofi 14,799
Large-scale testing (Phase 3)Study completedNCT00986765
What this trial is testing

Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia

Who this might be right for
Preeclampsia
Assistance Publique - Hôpitaux de Paris 257
Large-scale testing (Phase 3)Study completedNCT00673426
What this trial is testing

Safety Evaluation of Use Sodic Enoxaparin

Who this might be right for
Kidney Disease
Azidus Brasil 60
Post-approval studies (Phase 4)UnknownNCT04169269
What this trial is testing

Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban

Who this might be right for
Deep Vein ThrombosisVenous Thromboembolism
Florida Orthopaedic Institute 128
Not applicableUnknownNCT02085824
What this trial is testing

Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.

Who this might be right for
Hip OsteoarthritisBlood Loss
Centre of Postgraduate Medical Education 60
Early research (Phase 1)Study completedNCT01014403
What this trial is testing

Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)

Who this might be right for
Venous ThromboembolismTraumatic Brain Injury
University of Texas Southwestern Medical Center 62
Large-scale testing (Phase 3)Ended earlyNCT00680628
What this trial is testing

Clot Dissolving Treatment for Blood Clots in the Lungs

Who this might be right for
Pulmonary Embolism
Wake Forest University Health Sciences 83
Load More Results